U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

A Diabetes Pay-for-Performance Program and Risks of Cancer Incidence and Death in Patients With Type 2 Diabetes in Taiwan

Supporting Files Public Domain
File Language:
English


Details

  • Journal Article:
    Preventing Chronic Disease (PCD)
  • Personal Author:
  • Description:
    Introduction ; We sought to evaluate the effects of diabetes disease management through a diabetes pay-for-performance (P4P) program in Taiwan on risks of incident cancer and mortality among patients with type 2 diabetes. ; Methods ; We conducted a longitudinal observational cohort study using 3 population-based databases in Taiwan. Using propensity score matching, we compared patients with type 2 diabetes who enrolled in a P4P program with a similar group of patients who did not enroll in the in P4P program (non-P4P). Primary end points of interest were risks of incident cancer and all-cause, cancer-specific, and diabetes-related mortality. Total person-years and incidence and mortality rates per 1,000 person-years were calculated. Multivariable Cox proportional hazard models and competing risk regression were used in the analysis. ; Results ; Overall, our findings indicated that the diabetes P4P program was not significantly associated with lower risks of cancer incidence, but it was associated with lower risks of all-cause mortality (adjusted sub distribution hazard ratio aSHR, 0.59; 95% confidence interval CI, 0.55–0.63), cancer-specific mortality (aSHR, 0.85; 95% CI, 0.73–1.00), and diabetes-related mortality (aSHR, 0.54: 95% CI, 0.49–0.60). Metformin, thiazolidinediones, and α glucosidase inhibitors were associated with lower risks of cancer incidence and cancer-specific mortality. ; Conclusion ; Our findings provide evidence of the potential benefit of diabetes P4P programs in reducing risks of all-cause mortality and competing causes of death attributable to cancer-specific and diabetes-related mortality among type 2 diabetes patients.
  • Subjects:
  • Source:
    Prev Chronic Dis. 14.
  • DOI:
  • ISSN:
    1545-1151
  • Pubmed ID:
    28981404
  • Pubmed Central ID:
    PMC5645199
  • Document Type:
  • Place as Subject:
  • Location:
  • Volume:
    14
  • Download URL:
  • File Type:
    Filetype[PDF - 447.64 KB]
  • Collection(s):
  • Main Document Checksum:
    urn:sha-512:dd0241138d7d0c159581f7d131ebe62965c6c55bd5ee248b8c53ee9c49ae17694167af18ac87e16ecb21d184480a3e32dfae68f3ac79b7e909e39595c402a062
File Language:
English
ON THIS PAGE
 Was this page helpful?
 Found an issue?
Send us an email at:
CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.